- Home
- BOKF vs RYTM Comparison
BOKF vs RYTM Comparison
Compare BOKF & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BOKF
- RYTM
- Stock Information
- Founded
- BOKF 1910
- RYTM 2008
- Country
- BOKF United States
- RYTM United States
- Employees
- BOKF N/A
- RYTM N/A
- Industry
- BOKF Major Banks
- RYTM Biotechnology: Pharmaceutical Preparations
- Sector
- BOKF Finance
- RYTM Health Care
- Exchange
- BOKF Nasdaq
- RYTM Nasdaq
- Market Cap
- BOKF 6.0B
- RYTM 6.4B
- IPO Year
- BOKF N/A
- RYTM 2017
- Fundamental
- Price
- BOKF $113.77
- RYTM $99.50
- Analyst Decision
- BOKF Hold
- RYTM Strong Buy
- Analyst Count
- BOKF 9
- RYTM 13
- Target Price
- BOKF $113.33
- RYTM $109.77
- AVG Volume (30 Days)
- BOKF 215.5K
- RYTM 634.5K
- Earning Date
- BOKF 10-20-2025
- RYTM 11-04-2025
- Dividend Yield
- BOKF 2.00%
- RYTM N/A
- EPS Growth
- BOKF 17.28
- RYTM N/A
- EPS
- BOKF 8.36
- RYTM N/A
- Revenue
- BOKF $2,074,957,000.00
- RYTM $156,287,000.00
- Revenue This Year
- BOKF $6.67
- RYTM $46.10
- Revenue Next Year
- BOKF $7.10
- RYTM $60.39
- P/E Ratio
- BOKF $13.64
- RYTM N/A
- Revenue Growth
- BOKF 4.66
- RYTM 53.55
- 52 Week Low
- BOKF $85.08
- RYTM $45.91
- 52 Week High
- BOKF $121.58
- RYTM $106.52
- Technical
- Relative Strength Index (RSI)
- BOKF 62.28
- RYTM 53.31
- Support Level
- BOKF $108.69
- RYTM $95.88
- Resistance Level
- BOKF $115.62
- RYTM $102.79
- Average True Range (ATR)
- BOKF 2.25
- RYTM 3.28
- MACD
- BOKF 0.02
- RYTM -0.18
- Stochastic Oscillator
- BOKF 75.23
- RYTM 53.99
About BOKF BOK Financial Corporation
BOK Financial Corp is a financial institution in Oklahoma, and it provides a comprehensive range of nationally competitive financial products and services. Its operating segments consist of commercial banking, consumer banking, and wealth management. The company has various products and services, including cash management services, loans and deposits, fiduciary and insurance services, mortgage banking, and brokerage and trading services. It generates maximum revenue from the commercial banking segment. Its commercial banking segment includes lending, treasury and cash management services, and customer risk management products to small businesses, middle market, and larger commercial customers.
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.